Publication
Generative AI: A global guide to key IP considerations
Artificial intelligence (AI) raises many intellectual property (IP) issues.
US: It’s time to reconsider poison pill strategies
When stock prices drop for reasons unrelated to company fundamentals, those companies are vulnerable to opportunistic activists and potential unsolicited acquirors, who can otherwise acquire a large stake before filing a Schedule 13D or 13G or HSR Form. In addition, the CARES Act has provided for enhanced NOL carryback opportunities for some companies, increasing the need to protect their NOL assets. In both cases, companies need to consider measures to protect their shareholders to enable them to benefit from the return to more normal share prices or to realize the value of their NOL assets. In fact, 2020 has already seen a significant uptick in preemptive standard and NOL pill adoption.
View key areas public company boards should consider in the current environment.
Senior Associate
Email
amelia.zhang@nortonrosefulbright.com
Recent publications
Publication
NRF Director of Strategic Innovation & Design named Innovation leader of the year at the ILTA 2024 awards
We are delighted to announce that Al Hounsell, Director of Strategic Innovation & Legal Design based in our Toronto office, has been named 'Innovative Leader of the Year' at the International Legal Technology Association (ILTA) Awards.
Publication
TMT M&A trends: Road to recovery as sector looks to exploit technology deal drivers
After a lacklustre finish to 2022 when compared to the vintage year for M&A that was 2021, dealmakers expected 2023 to see the market continue to cool in most sectors, in response to the economic headwinds of rising inflation (with its corresponding impact on financing costs), declining market valuations, tightening regulatory scrutiny and increasing geopolitical tensions.
Subscribe and stay up to date with the latest legal news, information and events . . .